Detailansicht

Wissensnetz

Person

Clemens Aigner (1974-)

Chirurg

Name	Clemens Aigner
Zeit	1974- (Lebensdaten)
Ort	Linz (Geburtsort) Österreich
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med. MBA
Beruf	Chirurg (charakteristischer Beruf) Arzt Hochschullehrer
Variante	C. Aigner
Beziehung	Universitätsklinik für Thoraxchirurgie (Wien) Ruhrlandklinik Universitätsklinikum Essen Thoraxchirurgie (Thema)
Quelle	Homepage: https://www.thoraxchirurgie.or.at (Stand: 28.09.2023)
Datensatztyp	Person
GND-Nummer	1079361375
Datensatz-ID	1079361375
Beteiligt an alle anzeigen Correction: ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors Correction: The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy ASO Visual Abstract: The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database Evolutionary trajectories of small cell lung cancer under therapy Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer Alternative venous access sites for dual-lumen extracorporeal membrane oxygenation cannulation Ein Vergleich zwischen Segmentektomien und Lobektomien hinsichtlich des Lymphknotenupstagings bei primären Lungenkarzinomen im T1-/T2-Stadium Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of Metastasectomy Mediastinaler Pseudotumor – nekrotisierende und sklerosierende Mediastinitis mit Pseudomembranen Reversible occlusion of the pulmonary vasculature by transarterial embolisation with degradable starch microspheres: preclinical assessment in a human isolated lung perfusion model Lung Transplantation for Adult Respiratory Distress Syndrome after SARS-CoV-2 Infection Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancer Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard Tracheal Resection after Previous Treatment Provides Comparable Outcome to Primary Surgery Die aktuelle Therapie des asbestassoziierten malignen Pleuramesothelioms – Ein Experten-Konsensuspapier Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages Insights into immunometabolism: a dataset correlating the 18FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancer Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo Impact of COVID-19 on Lung Transplant Activity in Germany—A Cross-Sectional Survey SARS-CoV-2 nach Lungentransplantation: Eine Fallserie mit heterogenen Merkmalen im CT Perioperatives Outcome und Kosten-/Nutzenrechnung von thoraxchirurgischen Operationen mit dem DaVinci-Roboter Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells Extrakorporale Membranoxygenierung in der Thoraxchirurgie – Lungentransplantation Effectiveness of Robotic Lobectomy—Outcome and Learning Curve in a High Volume Center Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma Intrathoracic solitary fibrous tumor – an international multicenter study on clinical outcome and novel circulating biomarkers Robotic thoracic surgery results in shorter hospital stay and lower postoperative pain compared to open thoracotomy: a matched pairs analysis Same-day Routine Chest-X Ray After Thoracic Surgery is Not Necessary! Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Low-FEV1 Patients Thymomas and Thymic Carcinomas: Prognostic Factors and Multimodal Management Initial experience with oral valganciclovir for pre-emptive cytomegalovirus therapy after lung transplantation Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Clemens Aigner (1974-)

Correction: ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors

Correction: The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

ASO Visual Abstract: The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database

Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors

The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database

Evolutionary trajectories of small cell lung cancer under therapy

Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer

C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer

Alternative venous access sites for dual-lumen extracorporeal membrane oxygenation cannulation

Ein Vergleich zwischen Segmentektomien und Lobektomien hinsichtlich des Lymphknotenupstagings bei primären Lungenkarzinomen im T1-/T2-Stadium

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of Metastasectomy

Mediastinaler Pseudotumor – nekrotisierende und sklerosierende Mediastinitis mit Pseudomembranen

Reversible occlusion of the pulmonary vasculature by transarterial embolisation with degradable starch microspheres: preclinical assessment in a human isolated lung perfusion model

Lung Transplantation for Adult Respiratory Distress Syndrome after SARS-CoV-2 Infection

Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS

Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm

Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancer

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

Tracheal Resection after Previous Treatment Provides Comparable Outcome to Primary Surgery

Die aktuelle Therapie des asbestassoziierten malignen Pleuramesothelioms – Ein Experten-Konsensuspapier

Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma

Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC

Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages

Insights into immunometabolism: a dataset correlating the 18FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancer

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma

HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line

Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo

Impact of COVID-19 on Lung Transplant Activity in Germany—A Cross-Sectional Survey

SARS-CoV-2 nach Lungentransplantation: Eine Fallserie mit heterogenen Merkmalen im CT

Perioperatives Outcome und Kosten-/Nutzenrechnung von thoraxchirurgischen Operationen mit dem DaVinci-Roboter

Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer

Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer

The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma

Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III

Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells

Extrakorporale Membranoxygenierung in der Thoraxchirurgie – Lungentransplantation

Effectiveness of Robotic Lobectomy—Outcome and Learning Curve in a High Volume Center

Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma

Intrathoracic solitary fibrous tumor – an international multicenter study on clinical outcome and novel circulating biomarkers

Robotic thoracic surgery results in shorter hospital stay and lower postoperative pain compared to open thoracotomy: a matched pairs analysis

Same-day Routine Chest-X Ray After Thoracic Surgery is Not Necessary!

Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Low-FEV1 Patients

Thymomas and Thymic Carcinomas: Prognostic Factors and Multimodal Management

Initial experience with oral valganciclovir for pre-emptive cytomegalovirus therapy after lung transplantation

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension